CrushSCI.com
Journal Selection & Manuscript Polishing Services
JACC: CardioOncology journal cover Medicine
Back to journal directory

Review Cycle Records

JACC: CardioOncology

Elsevier SCIE OA
2026 Emerging Zone 12025 CAS Zone 1 TOP2025 JCR Q1
107.4Average days
93.5Median days
37Fastest days
242Longest days
1382025 publications

Paper Review Records

All Paper Review Records

10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

39 days

Statin Use Attenuates Leuprolide-Associated Coronary Atherosclerosis Progression

AuthorsAdithya K. Yadalam; Chang Liu; Marly van Assen; Nikhil T. Sebastian; Vishal R. Dhere; Bruce W. Hershatter; Pretesh R. Patel; Ashesh B. Jani; Carlo N. De Cecco; Stephanie M. Cantu; Anant Mandawat; Sagar A. Patel

AffiliationsDivision of Cardiology, Emory University School of Medicine, Atlanta, Georgia, USA; Department of Epidemiology, Emory University Rollins School of Public Health, Atlanta, Georgia, USA; Department of Radiology and Imaging Sciences, Emory University School of Medicine, Atlanta, Georgia, USA; Winship Cancer Institute of Emory University, Atlanta, Georgia, USA; Department of Radiation Oncology, Emory University School of Medicine, Atlanta, Georgia, USA

Source PDF DOI Publisher page
103 days

Sacubitril/Valsartan and Right Ventricular and Diastolic Function During Breast Cancer Therapy

AuthorsMari Nordbø Gynnild; Albulena Mecinaj Lilleaasen; Torgeir Wethal; Even O. Jakobsen; Victoria Vinje-Jakobsen; Siri Lagethon Heck; Stian Larsen; Assami Rösner; Havard Dalen; Torbjørn Omland; Geeta Gulati; Espen Holte

AffiliationsK.G. Jebsen Center for Cardiac Biomarkers, Institute of Clinical Medicine, University of Oslo, Norway; Department of Cardiology and Cardiothoracic Surgery, St Olavs University Hospital, Trondheim, Norway; Department of Circulation and Medical Imaging, Faculty of Medicine and Health Science, NTNU – Norwegian University of Science and Technology, Trondheim, Norway; Department of Cardiology, Division of Medicine, Akershus University Hospital, Norway; Stroke Unit, Clinic of Medicine, St Olavs University Hospital, Trondheim, Norway; Department of Neuromedicine and Movement Science, Faculty of Medicine and Health Science, NTNU – Norwegian University of Science and Technology, Trondheim, Norway; Department of Diagnostic Imaging, Akershus University, Hospital, Lørenskog, Norway; Department of Cardiology, Stavanger University Hospital, Stavanger, Norway; Department of Cardiology, Division of Cardiothoracic and Respiratory Medicine, University Hospital of North Norway, Tromsø, Norway; Department of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway; Department of Medicine, Levanger Hospital, Nord-Trøndelag Hospital Trust, Levanger, Norway; Department of Cardiology, Division of Medicine, Oslo University Hospital, Ullevål, Norway

Source PDF DOI Publisher page
140 days

Hemoglobin Decline After Oral Anticoagulation Initiation and Subsequent Cancer Detection in Patients With Atrial Fibrillation

AuthorsPil-Sung Yang; Jee Hyuk Byun; Hanjin Park; Daehoon Kim; Dongseon Kang; Young Shin Lee; Min Kim; Hong-Ju Kim; Han-Joon Bae; Jung-Hoon Sung; Boyoung Joung

AffiliationsDivision of Cardiology, Department of Internal Medicine, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Republic of Korea; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia, USA; Division of Cardiology, Department of Internal Medicine, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea; Division of Cardiology, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang, Republic of Korea; Division of Cardiology, Department of Internal Medicine, Kyung Hee University Hospital, Seoul, Republic of Korea; Division of Cardiology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea; Division of Cardiology, Department of Internal Medicine, Yeungnam University Medical Center, Yeungnam University College of Medicine, Daegu, Republic of Korea; Department of Cardiology, Daegu Catholic University School of Medicine, Daegu, Republic of Korea; Department of Cardiology, CHA Bundang Medical Center, CHA University, Seongnam, Republic of Korea

Source PDF DOI Publisher page
161 days

Divergent Effects of GnRH Agonist and GnRH Antagonist Treatment on Platelet Activity and Transcriptome

AuthorsAntonia Beitzen-Heineke; Matthew Siskin; Matthew Muller; Anshini Bhatt; Kathryn C. Hafertepe; Yuhe Xia; Minas Economides; David R. Wise; Jeffrey S. Berger

AffiliationsDepartment of Medicine, New York University Grossman School of Medicine, New York, New York, USA; Department of Oncology and Hematology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Department of Medicine, Laura and Isaac Perlmutter Cancer Center, New York University Langone Health, New York, New York, USA; Precision Medicine in the Department of Medicine, New York University Grossman School of Medicine, New York, New York, USA; Institute for Systems Genetics, New York University Grossman School of Medicine, New York, New York, USA

Source PDF DOI Publisher page
242 days

A Simple Clinical Risk Score to Improve Prediction of Anthracycline-Induced Cardiotoxicity

AuthorsDaniela Cardinale; Nicola Cosentino; Chiara Morocutti; Luisa Quaggiotti; Valeria Marenzi; Jesús Saldaña-García; Teresa López-Fernández; Luca Piacentini; Alice Bonomi; Giancarlo Marenzi

AffiliationsDivision of Cardioncology, European Institute of Oncology, I.R.C.C.S., Milan, Italy; Centro Cardiologico Monzino, I.R.C.C.S., Milan, Italy; Cardio-Oncology Unit, Department of Cardiology, La Paz University Hospital, IdiPAZ Research Institute, Madrid, Spain

Source PDF DOI Publisher page
84 days

A Clinically Applicable Conversion Formula Between NT-proBNP and BNP in Light-Chain Amyloidosis

AuthorsEli Muchtar; Allan S. Jaffe; Andrew Staron; Vaishali Sanchorawala; Heather Landau; Oren Pasvolsky; Rajshekhar Chakraborty; Suzanne Lentzsch; Morie A. Gertz; Angela Dispenzieri

AffiliationsDivision of Hematology, Mayo Clinic, Rochester, Minnesota; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota; Section of Hematology and Medical Oncology and the Amyloidosis Center, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, Massachusetts; Division of Hematologic Oncology, Memorial Sloan Kettering Cancer Center, New York, New York; The University of Texas MD Anderson Cancer Center, Houston, Texas; Division of Hematology/Oncology, Hebert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York

Source PDF DOI Publisher page
134 days

Cardiovascular-Kidney-Metabolic Syndrome Staging and Cancer Risk

AuthorsXixi Xiao; Jiayong Li; Yu Ning; Yunyao Yang; Zhen Ou; Bin Dong; Yugang Dong; Yi Li; Chen Liu; Yilong Wang; Ruicong Xue

AffiliationsDepartment of Cardiology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, PR China; Key NHC Key Laboratory of Assisted Circulation (Sun Yat-sen University), Guangzhou, PR China; National-Guangdong Joint Engineering Laboratory for Diagnosis and Treatment of Vascular Diseases, Guangzhou, PR China

Source PDF DOI Publisher page
68 days

Sacubitril/Valsartan in Anthracycline-Treated Patients

AuthorsLuigi Spadafora; Massimiliano Camilli

AffiliationsDepartment of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy; Division of Cardiology and Interventional Cardiology, Ospedale Santa Maria Goretti, Latina, Italy; Department of Cardiovascular Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; Department of Cardiovascular and Pulmonary Sciences, Catholic University of the Sacred Heart, Rome, Italy

Source PDF DOI Publisher page
37 days

A Bleeding Risk Score for Cancer-Associated Venous Thromboembolism in Patients Receiving Direct Oral Anticoagulants

AuthorsTomoyuki Nagai; Naohiko Nakanishi; Yugo Yamashita; Takeshi Morimoto; Seiichi Hiramori; Ryuki Chatani; Yuji Nishimoto; Nobutaka Ikeda; Yohei Kobayashi; Satoshi Ikeda; Kitae Kim; Masayuki Shiba; Toru Takase; Shuhei Tsuji; Maki Oi; Takuma Takada; Kazunori Otsui; Jiro Sakamoto; Yoshito Ogihara; Takeshi Inoue; Shunsuke Usami; Po-Min Chen; Kiyonori Togi; Norimichi Koitabashi; Kosuke Doi; Hiroshi Mabuchi; Yoshiaki Tsuyuki; Koichiro Murata; Kensuke Takabayashi; Hisato Nakai; Daisuke Sueta; Wataru Shioyama; Tomohiro Dohke; Takeshi Kimura; Satoaki Matoba

AffiliationsDepartment of Cardiovascular Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan; Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Department of Clinical Epidemiology, Hyogo Medical University, Nishinomiya, Japan; Department of Cardiology, Kokura Memorial Hospital, Kokura, Japan; Department of Cardiovascular Medicine, Kurashiki Central Hospital, Kurashiki, Japan; Division of Cardiology, Osaka General Medical Center, Osaka, Japan; Division of Cardiovascular Medicine, Toho University Ohashi Medical Center, Tokyo, Japan; Department of Cardiovascular Center, Osaka Red Cross Hospital, Osaka, Japan; Department of Cardiovascular Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan; Department of Cardiovascular Medicine, Kobe City Medical Center General Hospital, Kobe, Japan; Cardiovascular Center, The Tazuke Kofukai Medical Research Institute, Kitano Hospital, Osaka, Japan; Department of Cardiology, Kinki University Hospital, Osaka, Japan; Department of Cardiology, Japanese Red Cross Wakayama Medical Center, Wakayama, Japan; Department of Cardiology, Japanese Red Cross Otsu Hospital, Otsu, Japan; Department of Cardiology, Tokyo Women's Medical University, Tokyo, Japan; Department of General Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan; Department of Cardiology, Tenri Hospital, Tenri, Japan; Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, Tsu, Japan; Department of Cardiology, Shiga General Hospital, Moriyama, Japan; Department of Cardiology, Kansai Electric Power Hospital, Osaka, Japan; Department of Cardiology, Osaka Saiseikai Noe Hospital, Osaka, Japan; Division of Cardiology, Nara Hospital, Kinki University Faculty of Medicine, Ikoma, Japan; Department of Cardiovascular Medicine, Gunma University Graduate School of Medicine, Maebashi, Japan; Department of Cardiology, National Hospital Organization Kyoto Medical Center, Kyoto, Japan; Department of Cardiology, Koto Memorial Hospital, Higashiomi, Japan; Division of Cardiology, Shimada General Medical Center, Shimada, Japan; Department of Cardiology, Shizuoka City Shizuoka Hospital, Shizuoka, Japan; Department of Cardiology, Hirakata Kohsai Hospital, Hirakata, Japan; Department of Cardiovascular Medicine, Sugita Genpaku Memorial Obama Municipal Hospital, Obama, Japan; Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan; Department of Cardiovascular Medicine, Shiga University of Medical Science, Otsu, Japan; Division of Cardiology, Kohka Public Hospital, Koka, Japan

Source PDF DOI Publisher page
66 days

Upper Extremity Deep Vein Thrombosis in Cancer Patients

AuthorsOlivier Espitia; Alexis F. Guedon; Emma Courouve; Benjamin Brenner; Juan José López-Núñez; Romain Chopard; Alicia Lorenzo; Patricia Sigüenza; Son Truong Nguyen; Manuel Monreal

AffiliationsDepartment of Internal and Vascular Medicine, Nantes Université, CHU Nantes, l'Institut du Thorax, INSERM UMR 1087/CNRS UMR 6291, Team III Vascular & Pulmonary Diseases, Nantes, France; Department of Internal, Sorbonne Université, AP-HP, Hôpital Saint Antoine, Paris, France; Department of Haematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel; Department of Internal Medicine, Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain; Institut de Recerca Germans Trias i Pujol, Badalona, Barcelona, Spain; CIBER Enfermedades Respiratorias (CIBERES), Madrid, Spain; Department of Cardiology, University Hospital Jean Minjoz, Besançon, France; Department of Internal Medicine, Hospital Universitario La Paz, Madrid, Spain; Department of Hematology, Cho Ray Hospital, Ho Chi Minh City, Vietnam; Faculty of Health Sciences, UCAM—Universidad Católica San Antonio de Murcia, Murcia, Spain

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.